Processa Pharmaceuticals (PCSA) Return on Sales (2012 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Return on Sales came in at 0.0% in Q4 2016, up 2.0% YoY from 0.0% in Q1 2016, and up 116.27% on a QoQ basis from 0.01% in Q3 2016.
Processa Pharmaceuticals (PCSA) Return on Sales (2012 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 5 years of Return on Sales data on file, last reported at 0.0% in Q4 2016.
- Quarterly Return on Sales rose 2.0% year-over-year to 0.0% in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 0.0% (up 4.0% YoY) and the FY2016 annual result came in at 0.0%, up 4.0% from the prior year.
- Return on Sales rose to 0.0% in Q4 2016, from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2016 to a low of 1.04% in Q1 2014.
- A 5-year average of 0.16% and a median of 0.06% in 2013 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2014 — Return on Sales tumbled 62 bps — and 2015, when it surged 100 bps.
- Tracing PCSA's Return on Sales over 5 years: stood at 0.25% in 2012, then soared by 54 bps to 0.12% in 2013, then slumped by 321 bps to 0.48% in 2014, then soared by 96 bps to 0.02% in 2015, then surged by 112 bps to 0.0% in 2016.
- The last three Return on Sales figures came in at 0.0% (Q4 2016), 0.01% (Q3 2016), and 0.03% (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.03% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | -0.02% |
| Sep 30, 2015 | -0.04% |
| Jun 30, 2015 | -0.06% |
| Mar 31, 2015 | -0.05% |
| Dec 31, 2014 | -0.48% |
| Sep 30, 2014 | -0.15% |
| Jun 30, 2014 | -0.11% |
| Mar 31, 2014 | -1.04% |
| Dec 31, 2013 | -0.12% |
| Sep 30, 2013 | -0.06% |
| Jun 30, 2013 | -0.07% |
| Mar 31, 2013 | -0.43% |
| Dec 31, 2012 | -0.25% |
| Sep 30, 2012 | -0.12% |
| Jun 30, 2012 | -0.05% |